Endo Pharms Inc Company Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ENDO PHARMS INC, and what generic alternatives to ENDO PHARMS INC drugs are available?

ENDO PHARMS INC has four approved drugs.

There are thirteen US patents protecting ENDO PHARMS INC drugs.

There are eighty-one patent family members on ENDO PHARMS INC drugs in thirty-nine countries.

Summary for Endo Pharms Inc

International Patents:	81
US Patents:	13
Tradenames:	4
Ingredients:	4
NDAs:	4

Drugs and US Patents for Endo Pharms Inc

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Pharms Inc	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005		RX	Yes	Yes	8,003,353	See Plans and Pricing				See Plans and Pricing
Endo Pharms Inc	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005		RX	Yes	Yes	7,879,349	See Plans and Pricing	Y			See Plans and Pricing
Endo Pharms Inc	MEGACE ES	megestrol acetate	SUSPENSION;ORAL	021778-001	Jul 5, 2005	AB	RX	Yes	Yes	9,101,540	See Plans and Pricing	Y			See Plans and Pricing
Endo Pharms Inc	AVEED	testosterone undecanoate	INJECTABLE;INTRAMUSCULAR	022219-001	Mar 5, 2014		RX	Yes	Yes	8,338,395	See Plans and Pricing				See Plans and Pricing
Endo Pharms Inc	MEGACE ES	megestrol acetate	SUSPENSION;ORAL	021778-001	Jul 5, 2005	AB	RX	Yes	Yes	9,040,088	See Plans and Pricing				See Plans and Pricing
Endo Pharms Inc	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005		RX	Yes	Yes	7,404,489	See Plans and Pricing	Y			See Plans and Pricing
Endo Pharms Inc	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005		RX	Yes	Yes	8,940,714	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Endo Pharms Inc

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Pharms Inc	MEGACE ES	megestrol acetate	SUSPENSION;ORAL	021778-001	Jul 5, 2005	5,145,684	See Plans and Pricing
Endo Pharms Inc	MEGACE ES	megestrol acetate	SUSPENSION;ORAL	021778-001	Jul 5, 2005	6,592,903	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ENDO PHARMS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Nasal Spray	500 mcg/spray	➤ Subscribe	2017-04-28
➤ Subscribe	Injection	250 mg/mL	➤ Subscribe	2014-06-11

International Patents for Endo Pharms Inc Drugs

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Slovenia	1457208	See Plans and Pricing
European Patent Office	2263650	See Plans and Pricing
World Intellectual Property Organization (WIPO)	03086354	See Plans and Pricing
European Patent Office	1457208	See Plans and Pricing
Montenegro	00149	See Plans and Pricing
Russian Federation	2354381	See Plans and Pricing
Norway	335179	See Plans and Pricing
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Time limited offer for new users ▶ Get up to 3 months free